Literature DB >> 30066161

High-Dose Tanshinone IIA Suppresses Migration and Proliferation While Promoting Apoptosis of Astrocytoma Cells Via Notch-1 Pathway.

Wanliang Dong1, Yuankun Zhang2, Xuemei Chen3, Yanjie Jia4.   

Abstract

Malignant astrocytoma is the most common malignant tumor with strong invasion in the central nervous system. Tanshinone IIA is an effective compound to suppress cell proliferation and promote cell apoptosis. However, there is little research about the role of tanshinone IIA in the treatment of astrocytoma. This study aimed to investigate the effect of tanshinone IIA on migration, proliferation and apoptosis of astrocytoma cells. The efficacy of tanshinone IIA on migration, proliferation and apoptosis of astrocytoma cells were evaluated by flow cytometry and the assays of plate clone formation, CCK-8, wound healing and transwell migration. The protein molecule and signaling pathway were detected by western blot. High-dose tanshinone IIA suppressed migration and proliferation of astrocytoma cells while promoting apoptosis of astrocytoma cells. The western blot results showed that there were high Notch-1 protein expression and low c-Myc, MMP-9 and Bcl-2 activation in the high-dose tanshinone IIA group compared with the control group. High-dose tanshinone IIA suppresses astrocytoma cell proliferation, migration while promoting apoptosis through Notch-1 pathway. Tanshinone IIA may be used to develop new drugs for the treatment of astrocytoma.

Entities:  

Keywords:  Astrocytoma; C-Myc, Bcl-2; MMP-9; Notch-1 pathway; Tanshinone IIA

Mesh:

Substances:

Year:  2018        PMID: 30066161     DOI: 10.1007/s11064-018-2601-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  38 in total

1.  'Go or grow': the key to the emergence of invasion in tumour progression?

Authors:  H Hatzikirou; D Basanta; M Simon; K Schaller; A Deutsch
Journal:  Math Med Biol       Date:  2010-07-07       Impact factor: 1.854

Review 2.  Notch signaling.

Authors:  Lucio Miele
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

3.  Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.

Authors:  Josep Domingo-Domenech; Samuel J Vidal; Veronica Rodriguez-Bravo; Mireia Castillo-Martin; S Aidan Quinn; Ruth Rodriguez-Barrueco; Dennis M Bonal; Elizabeth Charytonowicz; Nataliya Gladoun; Janis de la Iglesia-Vicente; Daniel P Petrylak; Mitchell C Benson; Jose M Silva; Carlos Cordon-Cardo
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

Review 4.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

Review 5.  New insights of epithelial-mesenchymal transition in cancer metastasis.

Authors:  Yadi Wu; Binhua P Zhou
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-07       Impact factor: 3.848

6.  Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis.

Authors:  Jiajia Fu; Heqing Huang; Jiajun Liu; Rongbiao Pi; Jianwen Chen; Peiqing Liu
Journal:  Eur J Pharmacol       Date:  2007-04-27       Impact factor: 4.432

7.  SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B.

Authors:  Zhibin Yu; Yingnan Sun; Xiaoling She; Zeyou Wang; Shuai Chen; Zhiyong Deng; Yan Zhang; Qiang Liu; Qing Liu; Chunhua Zhao; Peiyao Li; Changhong Liu; Jianbo Feng; Haijuan Fu; Guiyuan Li; Minghua Wu
Journal:  J Hematol Oncol       Date:  2017-06-08       Impact factor: 17.388

8.  Immunophenotypic signature of primary glioblastoma multiforme: A case of extended progression free survival.

Authors:  Puneet Gandhi; Richa Khare; Nitin Garg; Sandeep Sorte
Journal:  World J Clin Cases       Date:  2017-06-16       Impact factor: 1.337

9.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

10.  The transcriptional landscape of αβ T cell differentiation.

Authors:  Michael Mingueneau; Taras Kreslavsky; Daniel Gray; Tracy Heng; Richard Cruse; Jeffrey Ericson; Sean Bendall; Matthew H Spitzer; Garry P Nolan; Koichi Kobayashi; Harald von Boehmer; Diane Mathis; Christophe Benoist; Adam J Best; Jamie Knell; Ananda Goldrath; Vladimir Joic; Daphne Koller; Tal Shay; Aviv Regev; Nadia Cohen; Patrick Brennan; Michael Brenner; Francis Kim; Tata Nageswara Rao; Amy Wagers; Tracy Heng; Jeffrey Ericson; Katherine Rothamel; Adriana Ortiz-Lopez; Diane Mathis; Christophe Benoist; Natalie A Bezman; Joseph C Sun; Gundula Min-Oo; Charlie C Kim; Lewis L Lanier; Jennifer Miller; Brian Brown; Miriam Merad; Emmanuel L Gautier; Claudia Jakubzick; Gwendalyn J Randolph; Paul Monach; David A Blair; Michael L Dustin; Susan A Shinton; Richard R Hardy; David Laidlaw; Jim Collins; Roi Gazit; Derrick J Rossi; Nidhi Malhotra; Katelyn Sylvia; Joonsoo Kang; Taras Kreslavsky; Anne Fletcher; Kutlu Elpek; Angelique Bellemare-Pelletier; Deepali Malhotra; Shannon Turley
Journal:  Nat Immunol       Date:  2013-05-05       Impact factor: 25.606

View more
  7 in total

1.  Tanshinone IIA reverses EGF- and TGF-β1-mediated epithelial-mesenchymal transition in HepG2 cells via the PI3K/Akt/ERK signaling pathway.

Authors:  Longkai Zhang; Weibin Lin; Xiaodan Chen; Gang Wei; Hailong Zhu; Shangping Xing
Journal:  Oncol Lett       Date:  2019-11-01       Impact factor: 2.967

2.  Tanshinone IIA suppresses ovarian cancer growth through inhibiting malignant properties and angiogenesis.

Authors:  Jin Zhou; Yuan-Yuan Jiang; Xiao-Xia Wang; Hai-Ping Wang; Huan Chen; Yi-Chao Wu; Long Wang; Xiang Pu; Gui-Zhou Yue; Li Zhang
Journal:  Ann Transl Med       Date:  2020-10

Review 3.  Targeting Oxidative Stress and Endothelial Dysfunction Using Tanshinone IIA for the Treatment of Tissue Inflammation and Fibrosis.

Authors:  Tsuo-Cheng Lu; Yi-Hsiu Wu; Wei-Yu Chen; Yu-Chiang Hung
Journal:  Oxid Med Cell Longev       Date:  2022-04-07       Impact factor: 7.310

4.  Effect of Notch1 signaling on cellular proliferation and apoptosis in human laryngeal carcinoma.

Authors:  Dawei Li; Dan Xu; Yifei Zhang; Penghui Chen; Jin Xie
Journal:  World J Surg Oncol       Date:  2022-08-19       Impact factor: 3.253

Review 5.  An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen).

Authors:  Irum Naz; Myriam Merarchi; Shanaya Ramchandani; Muhammad Rashid Khan; Muhammad Nouman Malik; Sumaira Sarwar; Acharan S Narula; Kwang Seok Ahn
Journal:  Explor Target Antitumor Ther       Date:  2020-06-29

Review 6.  The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients.

Authors:  Li Fu; Bing Han; Yang Zhou; Jie Ren; Wenzhi Cao; Gopal Patel; Guoyin Kai; Jun Zhang
Journal:  Front Pharmacol       Date:  2020-03-19       Impact factor: 5.810

7.  Tanshinone IIA Suppresses Glioma Cell Proliferation, Migration and Invasion Both in vitro and in vivo Partially Through miR-16-5p/Talin-1 (TLN1) Axis.

Authors:  Shihao You; Xianghui He; Mei Wang; Lina Mao; Lu Zhang
Journal:  Cancer Manag Res       Date:  2020-11-06       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.